Ubie vs Wysa
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Ubie
Japan's AI symptom checker — 20 questions, 3 minutes, no signup
Visit
|
Wysa
FDA Breakthrough-designated AI mental health companion delivering CBT...
Visit
|
|
|---|---|---|
| RECATOOLS Score | 7.8 / 10 | 7.8 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Freemium |
| Free tier | Core symptom checker free, no registration required | Core AI companion, limited CBT/DBT sessions, mood tracking — no credit card required |
| Paid from | Medical Navigator (AI問診) B2B is quote-based, not publicly disclosed | Premium ~USD 29.99/month; Enterprise custom pricing |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✓ | ✓ |
| Users | 10M+ monthly users globally; 1,800+ medical institutions in Japan (2025) | 6 million+ users; 500 million+ conversations across 95 countries |
| Founded | 2017 | 2015 |
| Maker | Ubie, Inc. | Touchkin eServices Private Limited |
| Verdict | Ubie clears a bar most AI symptom checkers don't bother with: published, peer-reviewed accuracy data. A 2024 medRxiv vignette study put its top-10 diagnostic hit rate at 71.6%, close to the 72.9% median for physicians on... |
An FDA Breakthrough Device Designation from May 2022 puts Wysa in rare company among consumer mental-health apps — regulatory validation, not just wellness-app marketing. NHS data backs it up: 31 Talking Therapies servic... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.